Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • chapterNo Access

    HYDROXYAPATITE TRICALCIUM PHOSPHATE AS A FILLER FOR INFECTED BONE DEFECTS

    Bioceramics01 Oct 1999

    Treatment of bone defects caused by infection is very difficult. If no filler is used, a dead space is created and this is a disadvantage for the healing of infection. However, filling the infected bone defect with free autogenous iliac bone graft also slows the healing of infection and bone absorption often occurs. We filled infected bone defects of 10 patients (6 men and 4 women; mean age: 48.1 years) with hydroxyapatite tricalcium phosphate (HAP-TCP) from 1992 to 1997. In all patients, methicillin-resistant Staphylococcus aureus was isolated from the infected focus. Administration of appropriate antibiotics and extended resection of the infected focus were performed, and the bone defect was packed with HAP-TCP after control of the infection. Wound healing, recurrence of infection, bone union, and HAP-TCP bonding were investigated. Wound healing was obtained in all patients and recurrence of infection did not occur. Bone union and HAP-TCP bonding were also obtained in all patients, and absorption of HAP-TCP did not occur. It is important for the treatment of infected bone defects that appropriate antibiotics are administered, the infected focus is excised completely, and the bone defect is filled adequately. When the former 2 conditions were fulfilled, HAP-TCP was not absorbed and was an effective filler for bone defects.